SCHEMBL5801152

SCHEMBL5801152

BrCCN1C=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31315772 0.86
Bromide SCHEMBL4471870 0.85
SCHEMBL28387767 0.85
SCHEMBL28950338 0.83
Bromide SCHEMBL22689612 0.83
SCHEMBL5435337 0.80
SCHEMBL1985304 0.78
Bromide SCHEMBL31536069 0.78
SCHEMBL1996789 0.76
SCHEMBL7219785 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101426786-A Benzazole potentiators of metabotropic glutamate receptors MERCK & CO INC (US) 2009-05-06 CN disclosed
WO-2006098624-A2 ANTI-VIRAL USE OF A COUMARIN AGENT RADEMAKER HOLDING B.V. (NL) 2006-09-21 WO disclosed
WO-2006098620-A1 USE OF DERIVATIVES COMPRISING A COUMARIN GROUP FOR THE PREPARATION OF AN ANTIVIRAL AGENT, DERIVATIVES COMPRISING A COUMARIN GROUP, A METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RADEMAKER HOLDING B.V. (NL) 2006-09-21 WO disclosed